Streptomycin: Difference between revisions
(added new page) |
(added new sections) |
||
| Line 44: | Line 44: | ||
===Plague=== | ===Plague=== | ||
* 15 mg/kg IM q12h x10 days | * 15 mg/kg IM q12h x10 days | ||
**Maximum dose: 2 g/day (adjust dose based on serum levels) | **Maximum dose: 2 g/day (adjust dose based on serum levels) | ||
===Tularemia=== | ===Tularemia=== | ||
* 15 mg/kg IM q12h x10 days | * 15 mg/kg IM q12h x10 days | ||
**Maximum dose: 2 g/day (adjust dose based on serum levels) | |||
==Special Populations== | |||
*[[Pregnancy Rating]]: D | |||
*Lactation: Probably Safe | |||
*Monitoring parameters: | |||
**BUN/Cr at baseline, then periodically. | |||
**Serum drug levels | |||
**Urinanalysis | |||
**Audiometry for high risk patients | |||
==Contraindications / Cautions== | |||
*Contraindicated: | |||
**BCG live intravesical | |||
**Cidofovir | |||
**Streptozocin | |||
*caution if hypersensitivity to sulfites | *caution if hypersensitivity to sulfites | ||
| Line 65: | Line 79: | ||
*caution in neonates or infants | *caution in neonates or infants | ||
*caution in elderly patients | *caution in elderly patients | ||
==Adverse Reactions== | |||
===Serious=== | |||
*Ototoxicity, auditory & vestibular | |||
*Neurotoxicity | |||
*Neuromuscular blockade | |||
*Nephrotoxicity | |||
*Anemia, hemolytic | |||
*Pancytopenia | |||
*Thrombocytopenia | |||
*Anaphylaxis | |||
*Angioedema | |||
*Hypersensitivity reaction | |||
*Exfoliative dermatitis | |||
*Superinfection | |||
===Common=== | |||
*Nausea/vomiting | |||
*Vertigo | |||
*Paresthesia, facial | |||
*Rash | |||
*Fever | |||
*Urticaria | |||
*Angioedema | |||
*Eosinophilia | |||
*Deafness | |||
*Exfoliative dermatitis | |||
*Anaphylaxis | |||
*Azotemia | |||
*Leukopenia | |||
*Thrombocytopenia | |||
*Pancytopenia | |||
*Anemia, hemolytic | |||
*muscle weakness | |||
*Amblyopia | |||
*Injection site reaction | |||
==Pharmacology== | |||
*Half-life: 5 hours | |||
*Metabolism: Unknown; CYP450 | |||
*Excretion: Urine | |||
*Mechanism of Action: Bactericidal (binds to 30S ribosomal subunit, inhibiting protein synthesis) | |||
==See Also== | ==See Also== | ||
| Line 70: | Line 127: | ||
==Source== | ==Source== | ||
Epocrates | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 22:02, 17 July 2014
General
- Type: Aminoglycosides
- Dosage Forms:
- IM
Adult Dosing
Infections, Bacterial
- 1-2 g/day IM divided q6-12h
- Max: 2 g/day; Info: adjust dose based on serum levels
- Renal dosing
- Creatinine Clearance 50-80: give q24h
- Creatinine Clearance 10-50: give q24-72h
- Creatinine Clearance <10: give q72-96h
Active tuberculosis
- 15 mg/kg IM q24h 5-7x/wk
- Alternative: 25-30 mg/kg IM 2-3x/wk
Plague
- 1g IM q12h x10 days
- Maximum dose: 2 g/day (adjust dose based on serum levels)
Tularemia
- 1g IM q12h x10 days
- Maximum dose: 2 g/day (adjust dose based on serum levels)
Pediatric Dosing
Infections, Bacterial
- 20-40 mg/kg IM q24h
- Alternative: 20-40 mg/kg IM 2x/wk
- Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk
- Renal dosing
- Creatinine Clearance 50-80: 7.5 mg/kg give q24h
- Creatinine Clearance 10-50: 7.5 mg/kg give q24-72h
- Creatinine Clearance <10: 7.5 mg/kg give q72-96h
Active tuberculosis
- 20-40 mg/kg IM q24h
- Alternative: 20-40 mg/kg IM 2x/wk
- Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk
Plague
- 15 mg/kg IM q12h x10 days
- Maximum dose: 2 g/day (adjust dose based on serum levels)
Tularemia
- 15 mg/kg IM q12h x10 days
- Maximum dose: 2 g/day (adjust dose based on serum levels)
Special Populations
- Pregnancy Rating: D
- Lactation: Probably Safe
- Monitoring parameters:
- BUN/Cr at baseline, then periodically.
- Serum drug levels
- Urinanalysis
- Audiometry for high risk patients
Contraindications / Cautions
- Contraindicated:
- BCG live intravesical
- Cidofovir
- Streptozocin
- caution if hypersensitivity to sulfites
- caution if impaired vestibular function
- caution if impaired auditory function
- caution if concurrent ototoxic agents
- caution if concurrent neurotoxic agents
- caution if neuromuscular disease
- caution if renal impairment
- caution if dehydration
- caution if concurrent nephrotoxic agent use
- caution if electrolyte abnormalities
- caution if prolonged use
- caution in neonates or infants
- caution in elderly patients
Adverse Reactions
Serious
- Ototoxicity, auditory & vestibular
- Neurotoxicity
- Neuromuscular blockade
- Nephrotoxicity
- Anemia, hemolytic
- Pancytopenia
- Thrombocytopenia
- Anaphylaxis
- Angioedema
- Hypersensitivity reaction
- Exfoliative dermatitis
- Superinfection
Common
- Nausea/vomiting
- Vertigo
- Paresthesia, facial
- Rash
- Fever
- Urticaria
- Angioedema
- Eosinophilia
- Deafness
- Exfoliative dermatitis
- Anaphylaxis
- Azotemia
- Leukopenia
- Thrombocytopenia
- Pancytopenia
- Anemia, hemolytic
- muscle weakness
- Amblyopia
- Injection site reaction
Pharmacology
- Half-life: 5 hours
- Metabolism: Unknown; CYP450
- Excretion: Urine
- Mechanism of Action: Bactericidal (binds to 30S ribosomal subunit, inhibiting protein synthesis)
See Also
Source
Epocrates
